Lenvervimab
Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2].
Product Specifications
CAS Number
[2055006-79-4]
Product Name Alternative
GC1102
UNSPSC
12352203
Target
HBV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lenvervimab.html
Purity
99
Solubility
10 mM in DMSO
Smiles
[Lenvervimab]
Molecular Weight
(147.526 kDa)
References & Citations
[1]Jeong GU, et al. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One. 2020 Aug 13;15 (8) :e0236704. |[2]Lee HW, et al. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020 Dec;18 (13) :3043-3045.e1.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1041709-01 0.02 mg (E-Coli)
Recombinant Enterobacter sp. Chorismate--pyruvate lyase (ubiC)
Ask
View Details 
MBS1041709-02 0.1 mg (E-Coli)
Recombinant Enterobacter sp. Chorismate--pyruvate lyase (ubiC)
Ask
View Details MBS1041709-03 0.02 mg (Yeast)
Recombinant Enterobacter sp. Chorismate--pyruvate lyase (ubiC)
Ask
View Details MBS1041709-04 0.1 mg (Yeast)
Recombinant Enterobacter sp. Chorismate--pyruvate lyase (ubiC)
Ask
View Details